Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Evaluating the role of epithelial basal cells in laryngeal homeostasis and disease development

Award Number: R01DC020176
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/2022
PERIOD OF PERFORMANCE END DATE: 05/31/2027

Group Awards By:

View Award Description

Evaluating the role of epithelial basal cells in laryngeal homeostasis and disease development - ABSTRACT The larynx requires protection from the ~25 million inhaled insults encountered daily during fulfillment of its normal functions including breathing, coughing, swallowing, and in humans, voice production. An epithelium forms a critical first protective barrier on the surface of the larynx. Under normal conditions, the epithelium relies on homeostatic regenerative mechanisms. The basal cell (BC) layer of the epithelium is believed to represent a reservoir of progenitor cells for the formation and regeneration of differentiated epithelium. However, pathological changes, or remodeling, occurs in the composition and organization of the laryngeal epithelium in response to inhaled insults, notably cigarette smoke (CS). Remodeling affects the ability of the epithelium to function as an effective barrier and predisposes the tissue to disease development. Despite the prevalence and likely importance of epithelial remodeling in CS-induced laryngeal disease, its etiology is poorly understood. This is due to a lack of basic knowledge of the mechanisms which dictate laryngeal epithelial homeostatic regeneration and permanent tissue remodeling linked to CS. Specifically, little is known about the biology of the BC population in normal epithelial homeostasis, injured, or diseased conditions. A paucity of research on laryngeal BC biology serves as a major barrier in the development of therapies to prevent and treat CS-diseased vocal folds. To address this unmet need, we propose to test the central hypothesis that BC are critical to the formation and maintenance of normal laryngeal epithelium and CS-induced alterations in BC biology are associated with epithelial remodeling and human disease development. We will test this hypothesis using a normal mouse model (AIM 1) and in vivo and in vitro models of CS exposure (AIM 2) to study laryngeal BC properties in differentiated epithelium, primary culture, and physiologically relevant three-dimensional epithelial cell culture systems. We also propose to evaluate how our in vivo and in vitro findings in mice relate to the human condition by evaluating the biology of BC in human laryngeal specimens from patients with Reinke’s edema, a common CS-induced laryngeal disease (AIM 3). Completion of these aims will demonstrate that BC have a central and irreplaceable role in laryngeal epithelial biology- they function as progenitor cells for normal epithelium and alterations in BC biology are implicated in disease development. Findings will have significant theoretical and clinical impact and will provide novel new insights into the mechanism underlying laryngeal and vocal fold epithelial regeneration. Targeting specific biologic pathways that mediate CS-induced derangements in BC biology may represent innovative therapeutic targets to prevent development and progression of CS- and other smoke-mediated voice disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $364,704 )
2026	2026	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Research Related to Deafness and Communication Disorders	000	5	5/5/2026	NON-COMPETING CONTINUATION	$364,704
														Subtotal = $364,704

Issue Date FY: 2025 ( Subtotal = $369,123 )
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Research Related to Deafness and Communication Disorders	000	4	5/7/2025	NON-COMPETING CONTINUATION	$369,123
														Subtotal = $369,123

Issue Date FY: 2024 ( Subtotal = $374,116 )
2024	2024	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Research Related to Deafness and Communication Disorders	000	3	5/8/2024	NON-COMPETING CONTINUATION	$374,116
														Subtotal = $374,116

Issue Date FY: 2023 ( Subtotal = $414,592 )
2023	2023	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Research Related to Deafness and Communication Disorders	000	2	5/22/2023	NON-COMPETING CONTINUATION	$414,592
														Subtotal = $414,592

Issue Date FY: 2022 ( Subtotal = $392,124 )
2022	2022	LELAND STANFORD JUNIOR UNIVERSITY, THE	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Research Related to Deafness and Communication Disorders	000	1	5/25/2022	NEW	$392,124
														Subtotal = $392,124

Grand Total All Awards = $1,914,659

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Evaluating the role of epithelial basal cells in laryngeal homeostasis and disease development

Award Number: R01DC020176

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/2022

PERIOD OF PERFORMANCE END DATE: 05/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer